Clinical trial
Liraglutide Use in Prader-Willi Syndrome
NCT01542242
Study timeline
Study start (unknown)2012-02-01Date precision: month
Registry last updated2015-12-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus Type 2unresolved
Prader Willi Syndromeunresolved
Interventions
LiraglutideDRUG · verified · RxNorm: liraglutide
Sponsors & collaborators
Vancouver General Hospitallead sponsor
Novo Nordisk A/Scollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01542242 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.